Advertisements


The Daily Biotech Pulse: Epizyme"s Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering

The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 13.) read more.....»»

Category: blogSource: benzingaFeb 14th, 2020

The Daily Biotech Pulse: Epizyme"s Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering

The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 13.) read more.....»»

Category: blogSource: benzingaFeb 14th, 2020

The Daily Biotech Pulse: Neurocrine"s Parkinson"s Drug Accepted For Review, Sunesis Offering, No Headaches For Biohaven"s Migraine Drug

Here's a roundup of top developments in the biotech space over the last 24 hours. read more.....»»

Category: blogSource: benzingaJul 11th, 2019

The Daily Biotech Pulse: Trevana Pain Drug Resubmission Accepted For Review, Can-Fite To Explore Treatment For COVID-19

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs .....»»

Category: earningsSource: benzingaMar 5th, 2020

The Daily Biotech Pulse: Trevana Pain Drug Resubmission Accepted For Review, Can-Fite To Explore Treatment For COVID-19

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 4) read more.....»»

Category: blogSource: benzingaMar 5th, 2020

The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 12) read more.....»»

Category: blogSource: benzingaFeb 13th, 2020

The Daily Biotech Pulse: Canadian Approval For Amarin"s Vascepa, Innate Pharma"s Blood Cancer Drug Accepted For Review In Europe

The following is a roundup of top developments in the biotech space over the last 24 hours.  Scaling The Peaks (Biotech stocks that hit 52-week highs on Dec. 31.) 0 read more.....»»

Category: blogSource: benzingaJan 2nd, 2020

The Daily Biotech Pulse: Takeda Pulls Plug On Amyloidosis Drug Trial, Chiasma Preps For Drug Launch With New CEO Appointment, Orchard Prices Offering

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on June 5) read more.....»»

Category: blogSource: benzingaJun 6th, 2019

Benzinga"s Daily Biotech Pulse: Epidiolex, Roche"s Influenza Drug Gets Priority Review Status, Xeris Jumps On Positive Trial Results

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on June 25) read more.....»»

Category: blogSource: benzingaJun 26th, 2018

Benzinga"s Daily Biotech Pulse: AbbVie Files sNDA For Leukemia Drug, AcelRx Offering, Aurinia Starts Mid-Stage Trial

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on July 11) read more.....»»

Category: blogSource: benzingaJul 12th, 2018

Benzinga"s Daily Biotech Pulse: Amgen Resubmits Osteoporosis Drug BLA, Auris Medical Prices Offering

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on July 12) Aerie Pharmaceuticals Inc (NASDAQ: AERI) Ar.....»»

Category: earningsSource: benzingaJul 13th, 2018

Benzinga"s Daily Biotech Pulse: Amgen Resubmits Osteoporosis Drug BLA, Auris Medical Prices Offering

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on July 12) read more.....»»

Category: blogSource: benzingaJul 13th, 2018

The Daily Biotech Pulse: Johnson & Johnson"s Generic Unit Files NDA For Urinary Tract Cancer Drug, G1 Therapeutics Prices Offering

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Sept. 18.) read more.....»»

Category: blogSource: benzingaSep 19th, 2018

The Daily Biotech Pulse: Novartis Positive Liver Drug Trials, Krytstal Prices Offering, LogicBio To Debut

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech stocks hitting 52-week highs on Oct. 18) read more.....»»

Category: blogSource: benzingaOct 19th, 2018

The Daily Biotech Pulse: EyePoint Licenses Eye Inflammation Drug, Insys Strategic Review Of Opioid Assets, Neos Offering

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech stocks hitting 52-week highs on Nov. 5) read more.....»»

Category: blogSource: benzingaNov 6th, 2018

The Daily Biotech Pulse: Exelixis Q4 Results, FDA Panel Greenlights J&J"s Depression Drug, MacroGenics Prices Offering

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Feb. 12) read more.....»»

Category: blogSource: benzingaFeb 13th, 2019

The Daily Biotech Pulse: Exelixis Q4 Results, FDA Panel Greenlights J&J"s Depression Drug, MacroGenics Prices Offering

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Feb. 12) Abbott Laboratories (NYSE: ABT) Amphastar Pharmac.....»»

Category: earningsSource: benzingaFeb 13th, 2019

The Daily Biotech Pulse: Positive Readout From Galapagos, Intersect ENT Strikes Distribution Deal, Sol Gel"s Regulatory Filing Accepted For Review

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 10) read more.....»»

Category: blogSource: benzingaSep 11th, 2020

The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study

Here's a roundup of top developments in the biotech.....»»

Category: earningsSource: benzingaFeb 20th, 2020

The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche"s Tecentriq sBLA

Here's a roundup of top developments in the biotech space over the .....»»

Category: earningsSource: benzingaFeb 19th, 2020

The Daily Biotech Pulse: FDA Snub For Merck, Priority Review For Roche"s Tecentriq sBLA

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 18) read more.....»»

Category: blogSource: benzingaFeb 19th, 2020